Research Materials / NCI Collaborator / NCH / using the Research Materials / /
Country
United States / /
Event
Business Partnership / M&A / Reorganization / /
Facility
Hospital Sarcoma / PPTP Investigator’s laboratory / Nationwide Children's Hospital / Medical Center Dr. / Children’s Hospital of Philadelphia / Albert Einstein Medical Center / Duke University / Children’s Hospital of Philadelphia Neuroblastoma Children’s Cancer Institute Australia / National Cancer Institute / his/her laboratory / Jude Children’s Research Hospital / Children’s Cancer Institute / Plant Variety Protection Act / /
IndustryTerm
Cancer Therapy / Cancer Treatment / chemical structure / /
National Cancer Institute / National Institute of Health / Cancer Treatment and Diagnosis Institution / St. Jude Children’s Research Hospital / Children’s Cancer Institute Australia / Institution of Confidential Information / Children’s Hospital / Cancer Institute Australia / Albert Einstein Medical Center / Texas Tech University / Duke University / Texas Tech University Health Sciences Center / Federal Government / Nationwide Children's Hospital / Medical Center / Division of Cancer Treatment / Government of the United States of America / Diagnosis Institution / Children’s Hospital of Philadelphia / /
Person
Richard Lock / Henry Friedman / Jianqiao Zhang / John Maris / Peter Houghton / Sherry Ansher / Thomas P. Clouse / C. Patrick Reynolds / Richard Gorlick / / /
Position
Investigator / Date PPTP Investigator / Principal Investigator / PPTP Investigator / Official / contractor / CLP Technology Transfer Specialist Technology Transfer Center / Investigator and Investigator / /
MATERIAL TRANSFER AGREEMENT The NCI-supported Pediatric Preclinical Testing Program (PPTP) is a comprehensive program to systematically evaluate new agents against childhood solid tumor and leukemia models. The PPTP is